IMATIFLOW (Imatinib IP 400 mg)

May 30, 2023

Imatinib IP (400 mg)
IMATIFLOW is a medication that belongs to a class of drugs called tyrosine kinase inhibitors. It is used in the treatment of certain types of cancer, including chronic myeloid leukemia (CML), gastrointestinal stromal tumors (GIST), and certain forms of acute lymphoblastic leukemia (ALL).
IMATIFLOW works by inhibiting the activity of specific tyrosine kinases, which are proteins involved in the abnormal growth and division of cancer cells. One of the main targets of this medication is the BCR-ABL tyrosine kinase, which is responsible for the uncontrolled proliferation of cells in CML. By blocking the activity of BCR-ABL, IMATIFLOW helps to suppress the growth of cancer cells and inhibit the progression of the disease.
STERIS PHARMA deals in Generic medicines that are subject to the same rigorous standards to ensure their safety, quality, and efficacy.
For further information
please contact: info@sterispharma.com
Order now:
https://www.sterisonline.com/product/imatiflow-400-133660

SHARE WITH